Am-is, Rhealyn S.
HRN: 24-70-98 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/27/2024
CEFUROXIME 500MG (TAB)
03/27/2024
04/03/2024
PO
500mg
BID X 7 Days
S/P NSVD With RMLE And Repair
Checking Final Appropriateness
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes